Non-toxic, edible batteries could one day power ingestible devices for diagnosing and treating disease. One team reports new progress toward that goal with their batteries made with melanin pigments, naturally found in the skin, hair and eyes.
The researchers will present their work today at the 252nd National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world’s largest scientific society, is holding the meeting here through Thursday. It features more than 9,000 presentations on a wide range of science topics.
“For decades, people have been envisioning that one day, we would have edible electronic devices to diagnose or treat disease,” says Christopher Bettinger, Ph.D. “But if you want to take a device every day, you have to think about toxicity issues. That’s when we have to think about biologically derived materials that could replace some of these things you might find in a RadioShack.”
About 20 years ago, scientists did develop a battery-operated ingestible camera as a complementary tool to endoscopies. It can image places in the digestive system that are inaccessible to the traditional endoscope. But it is designed to pass through the body and be excreted. For a single use, the risk that the camera with a conventional battery will get stuck in the gastrointestinal tract is small. But the chances of something going wrong would increase unacceptably if doctors wanted to use it more frequently on a single patient.
The camera and some implantable devices such as pacemakers run on batteries containing toxic components that are sequestered away from contact with the body. But for low-power, repeat applications such as drug-delivery devices that are meant to be swallowed, non-toxic and degradable batteries would be ideal.
“The beauty is that by definition an ingestible, degradable device is in the body for no longer than 20 hours or so,” Bettinger says. “Even if you have marginal performance, which we do, that’s all you need.”
While he doesn’t have to worry about longevity, toxicity is an issue. To minimize the potential harm of future ingestible devices, Bettinger’s team at Carnegie Mellon University (CMU) decided to turn to melanins and other naturally occurring compounds. In our skin, hair and eyes, melanins absorb ultraviolet light to quench free radicals and protect us from damage. They also happen to bind and unbind metallic ions. “We thought, this is basically a battery,” Bettinger says.
Building on this idea, the researchers experimented with battery designs that use melanin pigments at either the positive or negative terminals; various electrode materials such as manganese oxide and sodium titanium phosphate; and cations such as copper and iron that the body uses for normal functioning.
“We found basically that they work,” says Hang-Ah Park, Ph.D., a post-doctoral researcher at CMU. “The exact numbers depend on the configuration, but as an example, we can power a 5 milliWatt device for up to 18 hours using 600 milligrams of active melanin material as a cathode.”
Although the capacity of a melanin battery is low relative to lithium-ion, it would be high enough to power an ingestible drug-delivery or sensing device. For example, Bettinger envisions using his group’s battery for sensing gut microbiome changes and responding with a release of medicine, or for delivering bursts of a vaccine over several hours before degrading.
In parallel with the melanin batteries, the team is also making edible batteries with other biomaterials such as pectin, a natural compound from plants used as a gelling agent in jams and jellies. Next, they plan on developing packaging materials that will safely deliver the battery to the stomach.
When these batteries will be incorporated into biomedical devices is uncertain, but Bettinger has already found another application for them. His lab uses the batteries to probe the structure and chemistry of the melanin pigments themselves to better understand how they work.
The Latest on: Ingestible medical devices
via Google News
The Latest on: Ingestible medical devices
- FDA Faces Fresh Drug-Device Headaches After DC Circ. Losson April 20, 2021 at 6:07 pm
A new D.C. Circuit ruling will make it harder for the U.S. Food and Drug Administration to treat products as drugs when they fit into overlapping definitions of drugs and medical devices, experts say, ...
- Researchers Discover Potential of Smart Pills Marketon April 19, 2021 at 2:55 am
Increasing prevalence of gastro-intestinal diseases is expected to drive the smart pills market growth People above the age of 60 are more susceptible to Inflammatory Bowel Disease (IBD). Therefore, ...
- FDA Loses DC Circ. Appeal In Imaging Liquid Regulation Fighton April 16, 2021 at 6:27 pm
Henderson, the court affirmed a D.C. federal judge's order granting Genus Medical ... SilQ — an ingestible barium sulfate product for X-rays — as a drug rather than a medical device.
- Clinical Trials Market 2021: SWOT Analysis By Area…on April 16, 2021 at 2:30 am
Medical device and pharma giants are already eyeing better ... The ubiquity digital technologies is evidently growing, as these (including but not limited to ingestible devices, sensors, and wearable ...
- 2 Ways Miniaturized Medical Motors Save Liveson April 15, 2021 at 7:58 am
Miniaturization of mechanical motors, actuators, and electronic components saves lives in a small but significant way.
- Worldwide Disposable Medical Sensors Industry to 2025 - by Type, Product, Application and Region - ResearchAndMarkets.comon April 15, 2021 at 4:22 am
The "Disposable Medical Sensors: Technologies and Global ... the market is segmented into strip sensors, wearable sensors, ingestible sensors, implantable sensors, and invasive sensors.
- Integrated Device Design Critical to Rapid Medical IoT Developmenton April 13, 2021 at 5:00 pm
Medical IoT devices will enable more rapid detection of disease ... detector (a sensing and emitting light source), scientists and engineers have created an ingestible micro-bioelectronic device ...
- Ingestible Technologies for Diagnosis of Gastrointestinal Disorderson April 13, 2021 at 3:15 pm
CW: The PIL Dx will face standard development challenges as a regulated medical device that will undergo the FDA de novo pathway similar to other novel ingestible devices. This will include ...
via Bing News